A huge international medical trial could be a gamechanger for millions of people at risk of getting Alzheimer’s disease.
Researchers at 60 sites in the United States, Canada and Australia are getting ready to test an antibody that they believe could break-up a dangerous form of plaque that builds in the brain.
It is called amyloid plaque and this abnormal protein has the ability to kill nerve cells, triggering the dementia of Alzheimer’s.
The theory goes, detect the plaque early, destroy it, and the disease will never take hold.
For many years that was an illusive goal because the only way to find the plaque was through an autopsy. But a new form of imaging – the PET scan — is giving doctors the ability to find amyloid plaque years before the first symptoms of Alzheimer’s appear.
Read more . . .
The Latest on: Alzheimer’s
[google_news title=”” keyword=”Alzheimer’s” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Alzheimer’s
- Lecanemab's Promise and Peril: Alzheimer's Treatment Dilemmaon May 10, 2024 at 1:15 pm
The risks and benefits of lecanemab therapy were highlighted at the recent American Geriatrics Society conference.
- Research finds Alzheimer's may be passed down more than previously thoughton May 8, 2024 at 3:06 pm
Alzheimer's disease may be passed down in families more than previously thought. Genetic forms of Alzheimer's were thought to be incredibly rare and only occur at much younger ages. However, researchers in Spain and in the U.
via Bing News